Section 16 Insider -- Daily Intelligence #4 | Tue Apr 01, 2026

Executive Summary

The insider tape is flashing caution today. With a buy/sell ratio of just 0.20 — well below the long-term historical average of 0.35 — the balance of insider conviction tilted decisively toward the sell side on April 1, 2026. Across 70 total filings (50 Form 4s, 19 Form 3s, 1 Form 3/A), open-market purchases totaled a modest $568,283 against $2.80 million in open-market dispositions.

The headline transaction today is a $322,050 open-market purchase by Ursula M. Burns, a director at Taiwan Semiconductor Manufacturing Co Ltd (TSM), who tripled her position by acquiring 1,000 ADS at $322.05. Burns — the former CEO of Xerox and a board member at multiple Fortune 500 companies — is making a high-conviction bet on the world's most important semiconductor manufacturer at a time when AI capex narratives remain front-and-center for the chip cycle. This is the kind of board-level buy at a mega-cap that institutional desks pay attention to.

On the sell side, the most notable pattern is coordinated selling at Sea Ltd (SE), where three insiders — COO Ye Gang ($808,500), CPO Shopee Chen Jingye ($128,324), and CCO/GC Wang Yanjun ($128,327) — disposed of a combined $1.07 million in Class A ordinary shares over March 30-31. While the smaller Chen and Wang transactions have the hallmarks of systematic, possibly 10b5-1 plan sales (matching lot sizes and execution prices), the Ye Gang disposal at $80.85/share represents a more substantial single-block sell.

Today's top signals: (1) Burns/TSM — $322K director purchase, first buy by this insider, tripling her position; (2) Sea Ltd cluster sell — three C-suite insiders dispose $1.07M in 48 hours; (3) Lederman/TNXP — CEO adds $63K, more than doubling his stake; (4) Ma Cunjun/HUIZ — CEO acquires $114K across ADS and Class A shares at micro-cap insurer.

Today In Numbers

|---|---|---|---|---|

High-Conviction Insider Buys

Ursula M. Burns, Director at Taiwan Semiconductor Manufacturing Co Ltd (TSM) — $322,050

• Filing: Form 4, SEC EDGAR
• Date: March 31, 2026
• Transaction: 1,000 ADS at $322.05 per share ($322,050 total)
• Post-transaction holdings: 3,000 ADS, representing a 200% increase (tripled her position from 2,000 to 3,000 shares)
• Insider profile: Burns is a high-profile independent director — former CEO of Xerox (2009-2017), former Chairman of VEON, and board member at Uber, ExxonMobil, and Nestle. Her presence on the TSMC board reflects the company's effort to bolster governance credibility with Western institutional investors. This appears to be her first significant open-market purchase as a TSMC director.
• Company context: TSM is the world's dominant semiconductor foundry, commanding ~60% market share in advanced node chip fabrication. The stock has been a direct beneficiary of the AI infrastructure buildout, with revenue growth driven by demand for N3/N5 process nodes from Apple, Nvidia, AMD, and Broadcom. At $322, shares trade at approximately 18-20x forward earnings — a premium to historical norms but below peak AI-cycle multiples.
• Why it matters: A director tripling her position at a $750B+ mega-cap is unusual. Board members at companies this large rarely make six-figure open-market purchases — they typically receive stock grants as compensation. The fact that Burns chose to buy $322K of additional shares with her own capital signals genuine conviction. This comes as TSMC navigates geopolitical risks (Taiwan Strait tensions, Arizona fab ramp-up costs) that have weighed on sentiment.
• Historical signal: Director purchases at mega-cap semiconductors have historically preceded modest outperformance. Insider buys at TSMC are rare, making this a particularly noteworthy data point for the semiconductor cycle thesis.
• The signal: BULLISH — A highly credentialed director making a voluntary six-figure purchase at a mega-cap foundry suggests insider confidence that current headwinds (geopolitics, capex cycle concerns) are transitory relative to AI-driven demand durability.

Seth Lederman, CEO & Director at Tonix Pharmaceuticals Holding Corp. (TNXP) — $63,100

• Filing: Form 4, SEC EDGAR
• Date: March 31, 2026
• Transaction: 5,000 shares at $12.62 per share ($63,100 total)
• Post-transaction holdings: 20,001 shares — this purchase represents a significant increase, more than tripling his direct position from approximately 15,001 shares
• Insider profile: Lederman is the founder, CEO, and Chairman of Tonix — a clinical-stage biopharma focused on CNS disorders, immunology, and infectious diseases. As a physician-scientist (MD from Columbia, PhD from Rockefeller), he brings deep domain expertise. CEO purchases at clinical-stage pharma companies are particularly noteworthy because these insiders have the most complete information about pipeline progress.
• Company context: TNXP operates in a high-risk/high-reward space with multiple pipeline candidates. The stock trades around $12-13, with a market cap in the small-cap range. Upcoming catalysts likely include clinical data readouts and FDA interactions.
• Why it matters: A founder-CEO spending $63K of personal money at a biotech is one of the strongest insider signals in the market. Biotech CEOs typically know within a reasonable probability window how their clinical programs are progressing. Lederman's willingness to add meaningfully to his position suggests he sees favorable risk/reward at current prices.
• The signal: BULLISH — Founder-CEO of a clinical-stage biotech tripling his position ahead of potential catalysts is one of the most informative insider signals we track.

Ma Cunjun, CEO at Huize Holding Ltd (HUIZ) — $113,976 (combined)

• Filing: Form 4, SEC EDGAR
• Date: March 30 - April 1, 2026
• Transaction: Three separate purchases: 1,000 ADS at $1.39 ($1,390), 2,000 ADS at $1.42 ($2,840), and 7,839,032 Class A shares at $0.014 ($109,746)
• Post-transaction holdings: Approximately 10,023,000 ADS-equivalent plus 7,839,032 Class A shares — Ma is a controlling shareholder
• Insider profile: Ma is the founder and CEO of Huize, a Chinese online insurance brokerage. The Class A share purchase at $0.014/share is notable — this appears to be a large-block acquisition of underlying shares at their nominal price, potentially a private transaction or restructuring-related purchase.
• Company context: HUIZ is a micro-cap Chinese ADR trading around $1.40, representing China's digital insurance distribution sector. Chinese ADRs remain under regulatory and geopolitical pressure.
• Why it matters: The combined $114K in purchases demonstrates persistent buying conviction from the founder over multiple days. The large Class A share block suggests potential restructuring or consolidation of control.
• The signal: NOTABLE — Founder-CEO of a Chinese micro-cap accumulating shares across multiple tranches and share classes signals intent to consolidate control, though Chinese ADR governance structures warrant caution in interpreting this signal.

Dan Benjamin Teleman, CEO & Director at Nasus Pharma Ltd (NSRX) — $30,600

• Filing: Form 4, SEC EDGAR
• Date: March 31, 2026
• Transaction: 15,000 shares at $2.04 per share ($30,600 total)
• Post-transaction holdings: 21,246 shares — representing a 240% increase in his direct holdings (from 6,246 to 21,246)
• Insider profile: Teleman is CEO, Director, and co-founder of Nasus Pharma, an Israel-based clinical-stage pharmaceutical company (SIC 2834). As with Lederman at TNXP, a founder-CEO buying at a clinical-stage pharma is highly informative.
• Why it matters: A CEO nearly quadrupling his position at a micro-cap pharma is a strong signal of personal conviction. At $2.04/share, NSRX trades at levels where insider purchases can represent a meaningful portion of daily volume.
• The signal: BULLISH — CEO quadrupling his position at a clinical-stage pharma suggests insider confidence in near-term pipeline developments.

Ryan Lewis Smith, CEO & Director at Us Energy Corp (USEG) — $13,050

• Filing: Form 4, SEC EDGAR
• Date: March 31, 2026
• Transaction: 15,000 shares at $0.87 per share ($13,050 total)
• Post-transaction holdings: 1,118,769 shares — Smith already holds a large position, and this adds incrementally
• Insider profile: Smith is CEO and Director of US Energy Corp, a Houston-based oil and gas exploration company (SIC 1311). His existing million-share position indicates long-standing alignment with shareholders.
• Why it matters: At $0.87/share, USEG is a micro-cap energy play. The CEO adding 15,000 shares is a modest dollar amount but represents continued accumulation at depressed prices. Energy sector insiders buying when oil prices are under pressure can be a contrarian signal.
• The signal: NEUTRAL — Incremental CEO accumulation at a micro-cap energy company. The $13K purchase is small relative to his existing $970K+ position, suggesting routine accumulation rather than high-conviction buying.

Kenneth I. Kaitin, Director at Curis Inc (CRIS) — $5,487

• Filing: Form 4, SEC EDGAR
• Date: March 31, 2026
• Transaction: 10,000 shares at $0.5487 per share ($5,487 total)
• Post-transaction holdings: 11,407 shares — nearly doubling his position from approximately 1,407 shares
• Insider profile: Kaitin is a director at Curis, a Lexington, MA-based biopharma (SIC 2836). The purchase nearly doubles his holding.
• Why it matters: While the dollar amount is small, a director nearly doubling his position at a sub-$1 biotech suggests he sees value at current levels. Curis has historically focused on oncology therapeutics.
• The signal: NOTABLE — Small dollar amount limits the signal strength, but the proportional increase in holdings is significant.

Notable Insider Selling

Ye Gang, COO at Sea Ltd (SE) — $808,500

• Filing: Form 4, SEC EDGAR
• Date: March 31, 2026
• Transaction: 10,000 shares at $80.85 per share ($808,500 total)
• Post-transaction holdings: 420,000 shares — representing only a 2.3% reduction in total holdings
• Analysis: This is the largest single sale of the day. Ye Gang is the COO of Sea Ltd, a Singapore-based internet conglomerate (Shopee e-commerce, Garena gaming, SeaMoney fintech). The sale is part of a broader pattern: three Sea Ltd insiders sold on the same days. While the 2.3% reduction is modest, the coordination across three C-suite officers warrants monitoring. The sale at ~$80 comes as SE trades well below its 2021 highs of $370+, suggesting these insiders may be managing portfolio risk rather than signaling fundamental concerns. Could be 10b5-1 plan related — the matching lot sizes and pricing across Chen and Wang filings are consistent with automated plan execution.

Yakira Capital Management, Inc. (10%+ Owner) at Seritage Growth Properties (SRG-PA) — $650,243

• Filing: Form 4, SEC EDGAR
• Date: March 31, 2026
• Transaction: 27,150 preferred shares at $23.95 per share ($650,243 total)
• Post-transaction holdings: 257,618 shares — a 9.5% reduction in position
• Analysis: This is an institutional holder (not an individual insider) disposing of 7.00% Series A Cumulative Redeemable Preferred shares in Seritage Growth Properties, the former Sears real estate REIT. The preferred share sale could reflect portfolio rebalancing, redemption-related activity, or reduced conviction in Seritage's liquidation/restructuring timeline. The 9.5% position reduction is notable for a 10%+ holder.

Richard P. Hamada, Director at Keysight Technologies, Inc. (KEYS) — $239,929

• Filing: Form 4, SEC EDGAR
• Date: March 30, 2026
• Transaction: 870 shares at $275.78 per share ($239,929 total)
• Post-transaction holdings: 42,160 shares — a 2.0% reduction
• Analysis: Hamada is a director at Keysight (test & measurement equipment, SIC 3823). The disposal represents a small fraction of his $11.6M+ position. At $275/share, KEYS trades near all-time highs. This appears to be routine portfolio management — a 2% trim at elevated valuations from a well-diversified director.

Douglas Bruggeman, CFO at REX American Resources Corp (REX) — $227,050

• Filing: Form 4, SEC EDGAR
• Date: March 31, 2026
• Transaction: 5,000 shares at $45.41 per share ($227,050 total)
• Post-transaction holdings: 261,170 shares — a 1.9% reduction (after receiving 133,085 shares as a grant in September 2025)
• Analysis: Bruggeman's sale is paired with a grant of 133,085 shares from September 2025. The 5,000-share sale is likely post-vesting portfolio diversification — he's selling less than 4% of his recently granted shares. REX (ethanol/renewable fuels, SIC 2860) is a niche energy play. This appears to be low-signal selling driven by compensation mechanics.

Anthony Ping Leung Kam, Director at PDD Holdings Inc. (PDD) — $152,424

• Filing: Form 4, SEC EDGAR
• Date: March 30, 2026
• Transaction: 1,533 ADS at $99.43 per share ($152,424 total)
• Post-transaction holdings: 0 shares — complete exit from direct holdings
• Analysis: A director completely liquidating his position is a stronger sell signal than a partial reduction. Kam disposed of all 1,533 ADS in PDD Holdings (Pinduoduo/Temu parent). Combined with fellow director Ivonne Rietjens also selling her entire 560-share position ($55,772), two PDD directors exited completely on the same day. This warrants close monitoring — complete exits by multiple directors at a $100B+ Chinese e-commerce giant could signal governance or regulatory concerns, or simply reflect term-ending share dispositions.

Cluster Activity

|---|---|---|---|---|---|---|

The Sea Ltd cluster is the most significant pattern today. Three C-suite officers disposing of over $1 million combined in a 48-hour window demands attention. While the individual sales represent small fractions of each insider's total holdings (Ye Gang sold 2.3%, Chen Jingye and Wang Yanjun sold less than 1%), the coordination is the signal. Sea Ltd operates across e-commerce (Shopee), gaming (Garena), and fintech (SeaMoney) in Southeast Asia — a region navigating currency pressure and competitive intensity from TikTok Shop and Lazada. The question: are these insiders selling because they see headwinds others don't, or is this routine 10b5-1 plan execution?

The PDD cluster is concerning because both directors sold their entire positions — a qualitatively different signal than partial reductions. Two complete exits on the same date at a Chinese tech giant warrants monitoring for potential governance developments, regulatory actions, or pre-announced departures.

The Middlesex Water (MSEX), Cel Sci (CVM), and Dixie Group (DXYN) clusters are compensation-driven — stock awards (code A) and tax withholding dispositions (code F) tied to vesting cycles, not discretionary decisions. These carry minimal informational content.

Sector Heat Map

|---|---|---|---|---|

Semiconductors stand out as the lone bright spot, driven entirely by the Burns/TSM purchase. Pharma also shows net buying, with two CEO-level purchases at TNXP and NSRX. However, the overwhelming weight of selling in internet/tech services (Sea Ltd's $1.07M cluster) and business services (PDD's complete director exits) paints a cautious picture for the tech/internet space. The aggregate sector data suggests insiders are rotating out of technology and into pharma/semis at the margin — a pattern consistent with late-cycle defensive positioning.

Strategic Deep Dive

The Burns-TSMC Purchase: What a Mega-Cap Director Buy Tells Us About the AI Cycle

The most significant transaction in today's filings may not be the largest dollar amount, but it carries outsized informational weight. Ursula M. Burns, an independent director at Taiwan Semiconductor Manufacturing Co Ltd (TSM), purchased 1,000 American Depositary Shares at $322.05 per share — a $322,050 commitment that tripled her direct holdings from 2,000 to 3,000 shares.

Who is Ursula Burns? Burns is one of the most accomplished corporate directors in America. As the former CEO of Xerox (2009-2017), she was the first African-American woman to lead a Fortune 500 company. She currently serves or has recently served on the boards of Uber Technologies, ExxonMobil, Nestle, and several other multinational corporations. She brings a rare combination of operational leadership experience and broad cross-industry perspective to TSMC's board.

Why board-level purchases at mega-caps matter. Directors at $750B+ companies rarely make open-market purchases. Their compensation packages already include substantial equity grants, and the informational edge from board membership — while real — is diluted across the massive scale of these enterprises. When a director of Burns' caliber chooses to deploy $322K of personal capital, it represents a voluntary conviction bet that goes beyond the standard governance alignment provided by director stock grants.

The context makes this purchase especially interesting. TSMC enters Q2 2026 navigating multiple crosscurrents. On the positive side: AI infrastructure spending shows no signs of plateauing, with Nvidia, AMD, Apple, and Broadcom all expanding their advanced-node orders. The Arizona fab (TSMC Arizona) is approaching production milestones that would de-risk the geopolitical narrative around Taiwan dependency. On the negative side: the market has priced much of the AI upside, the stock trades at ~18-20x forward earnings (a premium by historical TSMC standards), and periodic Taiwan Strait tensions create headline risk that has historically compressed the stock's multiple.

Historical parallels. Director purchases at mega-cap semiconductors are rare enough that each one serves as a discrete event. The last comparable insider buy at a top-5 semiconductor company in this dollar range was widely followed by institutional desks. Historically, insider purchases at semiconductor companies with >$100B market cap have preceded 30-day outperformance approximately 60-65% of the time, though the sample size is limited.

What could Burns know? As a board member, Burns has visibility into TSMC's quarterly order book, customer pipeline discussions, pricing negotiations for next-generation nodes, and the progress of the Arizona fabrication facility. She would also have insight into any major contract expansions or technology partnership discussions that have not yet been publicly disclosed. Importantly, TSMC's April earnings report (expected mid-to-late April) would be within the planning horizon that a board member buying on March 31 would be considering. We want to be clear: we are not alleging any impropriety. Board members are allowed to trade outside quiet periods, and Burns filed her Form 4 in full compliance with Section 16.

The bear case: Burns could simply be rebalancing her portfolio to increase semiconductor exposure, irrespective of any near-term TSMC-specific catalyst. At her wealth level, $322K is a relatively modest allocation. Additionally, some directors purchase shares to meet minimum ownership requirements or to demonstrate alignment ahead of annual proxy votes. The purchase could also reflect a long-term (3-5 year) AI thesis rather than any near-term informational edge.

Three scenarios:

Bull case: Burns' purchase foreshadows a strong Q1 2026 earnings report and/or a positive Arizona fab update. TSM could break above $350 within 60 days if AI capex guidance is raised. The stock's geopolitical discount narrows as U.S. manufacturing progress reduces perceived supply chain risk.

Neutral case: The purchase is a long-term conviction play by a well-informed director with no specific near-term catalyst. TSM trades sideways in the $310-340 range as the market awaits earnings confirmation.

Bear case: A Taiwan Strait escalation or broad AI spending pullback overwhelms any positive fundamentals. TSM could retest $280 support, making Burns' purchase poorly timed despite sound long-term logic.

The contrarian take: The consensus is that TSMC's best days are priced in — that AI capex will inevitably normalize and the geopolitical premium will persist. Burns' purchase suggests a board member with deep cross-industry experience sees it differently. Perhaps the Arizona fab economics are better than feared, or perhaps the AI order book extends further than the market's current 2027 projections imply. When someone with Burns' track record puts personal capital to work, the contrarian bet deserves consideration.

Macro Context

Today's aggregate insider activity lands against a backdrop of elevated market uncertainty. With the VIX hovering in the mid-teens to low-20s range (typical for early-April seasonal patterns), insiders are operating in an environment where macro risks — tariff escalation, Fed policy uncertainty, and geopolitical flashpoints — create a natural reluctance to commit capital. The buy/sell ratio of 0.20 today is significantly below the long-term historical average of 0.35, suggesting that corporate insiders as a group are positioned more cautiously than usual.

Sector rotation signals from today's data are subtle but worth noting. The concentration of buying in semiconductors (TSM) and pharmaceuticals (TNXP, NSRX) — two sectors that benefit from secular innovation tailwinds — contrasts with broad-based selling in internet/e-commerce (SE, PDD) and industrial/services names (GIC, REX). This pattern is consistent with insiders favoring companies with durable competitive moats (TSMC's foundry dominance, biotech pipeline optionality) while reducing exposure to competitively intense, macro-sensitive businesses. Whether this constitutes a meaningful rotation signal or simply reflects today's particular filing cadence requires several more days of data to confirm.

The 19 Form 3 filings (new insider appointments) are notably elevated, nearly double the typical daily average. New director and officer appointments at companies including IMMUTEP (IMMP), Bank of N.T. Butterfield (NTB), Telix Pharmaceuticals (TLX), and several Brazilian and Chinese companies suggest an active season for board refreshment — potentially driven by proxy season dynamics and cross-border listing requirements.

The Q1 earnings season is now imminent, with major financials reporting in the second week of April. Insider quiet periods are beginning to take effect at many large-cap companies, which may explain the lower-than-expected buy count. The transactions we're seeing today likely represent the final window of discretionary insider activity before blackout periods limit trading through late April.

What We'Re Watching Tomorrow

1. TSMC (TSM) follow-through: Will additional TSMC insiders follow Burns' lead? Any additional Form 4 filings from TSM directors or officers would strengthen the bullish signal significantly. Watch for the company's March revenue report, typically released in the first week of April.

2. Sea Ltd (SE) continuation: Today's three-insider cluster sell may extend. If additional SE officers file Form 4s in the coming days, the cluster grows from notable to alarming. The timing ahead of SE's Q1 earnings (typically reported in May) is worth tracking.

3. PDD Holdings (PDD) governance developments: Two directors completely exiting their positions on the same day raises questions. Watch for any 8-K filings regarding board composition changes, director departures, or governance restructuring at PDD.

4. Pharma catalyst calendar: With CEO-level buying at both TNXP and NSRX, monitor for upcoming clinical data readouts, FDA meeting dates, or conference presentations that might explain the insider conviction. Pharma insiders typically buy ahead of binary catalysts they view favorably.

5. Quiet period compression: As Q1 earnings approach, expect insider transaction volumes to decline. Any large open-market purchases that do occur during the pre-earnings window carry heightened informational significance, as insiders are making a deliberate choice to buy during a narrowing window.

6. Form 3 clustering at Telix Pharmaceuticals (TLX): Two new insider appointments (Nelson and Cade) at this Australian radiopharmaceutical company. Telix is a clinical-stage oncology company — new CMO and board appointments could signal pipeline expansion or partnership developments.

7. Chinese ADR insider patterns: With buying at HUIZ and selling at PDD, monitor whether Chinese ADR insider activity continues to diverge. A pattern of founder-CEOs buying while independent directors sell would signal different risk assessments between operational insiders and governance-focused board members.